Genomic Valley Biotech Limited (BOM:539206)
India flag India · Delayed Price · Currency is INR
41.56
+1.97 (4.98%)
At close: Oct 27, 2026

Genomic Valley Biotech Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
127861791066676
Market Cap Growth
42.82%-52.21%68.80%59.59%-12.12%4.87%
Enterprise Value
127851751066676
Last Close Price
41.5628.0058.5934.7121.7524.75

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
613.30282.2350.26698.3510.25-
PS Ratio
58.9131.9721.2164.232.44107.14
PB Ratio
3.232.184.592.991.882.63
P/TBV Ratio
3.232.184.592.991.882.63
P/FCF Ratio
--1012.58---
P/OCF Ratio
--666.52---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
58.7931.9520.7163.982.44107.03
EV/EBITDA Ratio
-195.3439.77694.007.55-
EV/EBIT Ratio
-213.4240.00747.677.62-
EV/FCF Ratio
--988.92---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.01-0.01-0.010.00-0.010.00
Net Debt / EBITDA Ratio
-0.77-0.60-0.10-0.40-0.050.01
Net Debt / FCF Ratio
-1.38-2.560.300.050.00
Asset Turnover
-0.060.190.040.660.01
Quick Ratio
-7.314.933.212.530.08
Current Ratio
-8.415.733.682.895.31
Return on Equity (ROE)
-0.77%9.57%0.43%20.24%-0.25%
Return on Assets (ROA)
-0.58%6.29%0.20%13.25%-5.00%
Return on Invested Capital (ROIC)
0.52%0.78%9.54%0.40%27.35%-10.26%
Return on Capital Employed (ROCE)
-1.00%11.20%0.40%24.70%-12.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
0.16%0.35%1.99%0.14%9.76%-0.12%
FCF Yield
-0.15%-0.22%0.10%-0.19%-11.72%-28.17%
Buyback Yield / Dilution
2.08%0.43%-0.24%0.70%1.79%-1.91%